Entertainment

Covid-19 antibody drug that could treat and prevent infection enters phase 3 trial, says Regeneron

An antibody cocktail is now beginning late-stage clinical trials to assess the drug’s ability to prevent and treat coronavirus infection. © Regeneron New York State biotechnology company Regeneron is working on antibody therapy to treat and possibly prevent Covid-19. Biotech company Regeneron announced late-stage clinical trials of REGN-COV2, its investigational …

Read More »